Covid-19 Vaccination Centre

BY APPOINTMENT ONLY!
WE ARE UNABLE TO TAKE BOOKINGS OVER THE PHONE

If you’re over 45? Or Clinically extremely vulnerable
PLEASE USE LINK BELOW TO BOOK ONLINE

Book covid vaccince parkviewParkview Pharmacy will be running their Covid-19 Vaccination Programme from Thursday 21st January 2021. The Vaccination will take place inside a purpose built hub at the rear of the main pharmacy. Please follow arrows provided, note vaccines are currently given strictly by appointment only.

The hub will be supervised at all times by a GPHC Registered Pharmacist

If you have a query regarding our Covid-19 Vaccination Programme, please do not call the practice. Instead please contact via our form staff member will try and contact you within 72 hours. Please note that we cannot book appointments or respond to emergencies on this email.

If attending the practice for Covid-19 Vaccination Clinics (or any other reason) please ensure that you wear a face covering or mask at all times.

Note: The main covid centre is not accessible via wheelchair,
please ask in Pharmacy for assistance.

There is ample parking on the parade in front of the shops on Bramley road and also on South Lodge Drive and Belgrave Gardens (The 2-3pm parking restrictions have been waived until 30th April 2021 at least)

Caution

Please do not attend the Covid-19 Vaccination Centre or the main pharmacy if you have:

A COUGH

A FEVER

SHORTNESS OF BREATH

LOSS OF SMELL

Join our waiting list

  • Date Format: DD slash MM slash YYYY

Definition of clinically extremely vulnerable groups

People who are defined as clinically extremely vulnerable are at very high risk of severe illness from coronavirus. There are 2 ways you may be identified as clinically extremely vulnerable:

  1. You have one or more of conditions listed below, or
  2. Your clinician or GP has added you to the Shielded Patient List because, based on their clinical judgement, they deem to you be at higher risk of serious illness if you catch the virus.

If you do not fall into any of these categories, and have not been contacted to inform you that you are on the Shielded Patient List, follow the national lockdown guidance for the rest of the population.

If you think there are good clinical reasons why you should be added to the Shielded Patient List, discuss your concerns with your GP or hospital clinician. People with the following conditions are automatically deemed clinically extremely vulnerable:

 

Appendix 1

 

Green Book at risk category

 

Green Book full definition

 

 

Chronic respiratory disease

Individuals with a severe lung condition, including those with asthma that requires continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission, and chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema; bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD).
 

Chronic heart disease and vascular disease

Congenital heart disease, hypertension with cardiac complications, chronic heart failure, individuals requiring regular medication and/or follow-up for ischaemic heart disease. This includes individuals with atrial fibrillation, peripheral vascular disease or a history of venous thromboembolism.
Chronic kidney disease Chronic kidney disease at stage 3, 4 or 5, chronic kidney failure, nephrotic syndrome, kidney transplantation.
Chronic liver disease Cirrhosis, biliary atresia, chronic hepatitis.
 

 

 

Chronic neurological disease

Stroke, transient ischaemic attack (TIA). Conditions in which respiratory function may be compromised due to neurological disease (e.g. polio syndrome sufferers). This includes individuals with cerebral palsy, severe or profound learning disabilities, Down’s Syndrome, multiple sclerosis, epilepsy, dementia, Parkinson’s disease, motor neurone disease and related or similar conditions; or hereditary and degenerative disease of the nervous system or muscles; or severe neurological disability.
Diabetes mellitus Any diabetes, including diet-controlled diabetes.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Immunosuppression

Immunosuppression due to disease or treatment, including patients undergoing chemotherapy leading to immunosuppression, patients undergoing radical radiotherapy, solid organ transplant recipients, bone marrow or stem cell transplant recipients, HIV infection at all stages, multiple myeloma or genetic disorders affecting the immune system (e.g. IRAK-4, NEMO, complement disorder, SCID). Individuals who are receiving immunosuppressive or immunomodulating biological therapy including, but not limited to, anti-TNF, alemtuzumab, ofatumumab, rituximab, patients receiving protein kinase inhibitors or PARP inhibitors, and individuals treated with steroid sparing agents such as cyclophosphamide and mycophenolate mofetil. Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to prednisolone at 20mg or more per day for adults. Anyone with a history of haematological malignancy, including leukaemia, lymphoma, and myeloma and those with systemic lupus erythematosus and rheumatoid arthritis, and psoriasis who may require long term immunosuppressive treatments. Most of the more severely immunosuppressed individuals in this group should already be flagged as CEV. Individuals who are not yet on the CEV list but who are about to receive highly immunosuppressive interventions or those whose level of immunosuppression is about to increase may be therefore be offered vaccine alongside the CEV group, if therapy can be safely delayed or there is sufficient time (ideally two weeks) before therapy commences. Some immunosuppressed patients may have a suboptimal immunological response to the vaccine (see Immunosuppression and HIV).
Asplenia or dysfunction of the spleen This also includes conditions that may lead to splenic dysfunction, such as homozygous sickle cell disease, thalassemia major and coeliac syndrome.
Morbid obesity Adults with a Body Mass Index ≥40 kg/m²
Severe mental illness Individuals with schizophrenia or bipolar disorder, or any mental illness that causes severe functional impairment.

Frequently asked questions

COVID-19 Vaccine AstraZeneca is a vaccine used to protect people aged 18 years and older against COVID-19.

COVID-19 is caused by a virus called coronavirus (SARS-CoV-2).

COVID-19 Vaccine AstraZeneca stimulates the body’s natural defences (immune system). It causes the body to produce its own protection (antibodies) against the virus. This will help to protect you against COVID-19 in the future. None of the ingredients in this vaccine can cause COVID-19.

Menu